RAFFERTY ASSET MANAGEMENT, LLC Global Blood Therapeutics, Inc. Transaction History

RAFFERTY ASSET MANAGEMENT, LLC portfolio value:

$6.97M
portfolio value

RAFFERTY ASSET MANAGEMENT, LLC quarter portfolio value change:

+113.15%
quarter

Global Blood Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -40.36% -69.29K shares 1.48M $68.1 102.39K
Q2 2022 share Decrease -12.09% -23.60K shares -1.28M $31.95 171.68K
Q1 2022 share Increase +0.74% 1.42K shares 1.09M $34.64 195.29K
Q4 2021 share Increase +68.02% 78.48K shares 2.73M $29.86 193.86K
Q3 2021 share Increase +79.77% 51.2K shares 692K $25.48 115.38K
Q2 2021 share Decrease -15.19% -11.49K shares -836K $35.02 64.18K
Q1 2021 share Increase +229.34% 52.69K shares 2.08M $40.75 75.67K
Q4 2020 share Decrease -38.90% -14.62K shares -1.07M $43.31 22.97K
Q3 2020 share Increase +146.64% 22.35K shares 1.11M $55.14 37.60K
Q2 2020 share Increase +153.75% 9.23K shares 656K $63.13 15.24K
Q1 2020 share Decrease -88.22% -45.02K shares -3.74M $51.09 6.00K
Q4 2019 share Decrease -57.47% -68.94K shares -1.76M $79.49 51.02K
Q3 2019 share Increase +30.99% 28.38K shares 1.00M $48.52 119.97K
Q2 2019 share Decrease -7.63% -7.56K shares -430K $52.6 91.58K
Q1 2019 share Increase 0.00% 99.14K shares 5.24M $52.93 99.14K